ID   BECN1_HUMAN             Reviewed;         450 AA.
AC   Q14457; B2R6N7; O75595; Q9UNA8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   28-JUN-2023, entry version 213.
DE   RecName: Full=Beclin-1;
DE   AltName: Full=Coiled-coil myosin-like BCL2-interacting protein;
DE   AltName: Full=Protein GT197;
DE   Contains:
DE     RecName: Full=Beclin-1-C 35 kDa {ECO:0000303|PubMed:21364619};
DE   Contains:
DE     RecName: Full=Beclin-1-C 37 kDa {ECO:0000303|PubMed:21364619};
GN   Name=BECN1; Synonyms=GT197;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH BCL-2.
RC   TISSUE=Brain;
RX   PubMed=9765397; DOI=10.1128/jvi.72.11.8586-8596.1998;
RA   Liang X.H., Kleeman L.K., Jiang H.H., Gordon G., Goldman J.E., Berry G.,
RA   Herman B., Levine B.;
RT   "Protection against fatal Sindbis virus encephalitis by beclin, a novel
RT   Bcl-2-interacting protein.";
RL   J. Virol. 72:8586-8596(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10395800; DOI=10.1006/geno.1999.5851;
RA   Aita V.M., Liang X.H., Murty V.V.V.S., Pincus D.L., Yu W., Cayanis E.,
RA   Kalachikov S., Gilliam T.C., Levine B.;
RT   "Cloning and genomic organization of beclin 1, a candidate tumor suppressor
RT   gene on chromosome 17q21.";
RL   Genomics 59:59-65(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-450.
RC   TISSUE=Mammary gland;
RX   PubMed=7490091; DOI=10.1006/geno.1995.1185;
RA   Rommens J.M., Durocher F., McArthur J., Tonin P., Leblanc J.-F., Allen T.,
RA   Samson C., Ferri L., Narod S., Morgan K., Simard J.;
RT   "Generation of a transcription map at the HSD17B locus centromeric to BRCA1
RT   at 17q21.";
RL   Genomics 28:530-542(1995).
RN   [6]
RP   INTERACTION WITH BCL2, AND MUTAGENESIS OF PHE-123.
RX   PubMed=16179260; DOI=10.1016/j.cell.2005.07.002;
RA   Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N.,
RA   Packer M., Schneider M.D., Levine B.;
RT   "Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.";
RL   Cell 122:927-939(2005).
RN   [7]
RP   INTERACTION WITH BCL2L1, AND MUTAGENESIS OF LEU-116 AND PHE-123.
RX   PubMed=17446862; DOI=10.1038/sj.emboj.7601689;
RA   Maiuri M.C., Le Toumelin G., Criollo A., Rain J.C., Gautier F., Juin P.,
RA   Tasdemir E., Pierron G., Troulinaki K., Tavernarakis N., Hickman J.A.,
RA   Geneste O., Kroemer G.;
RT   "Functional and physical interaction between Bcl-X(L) and a BH3-like domain
RT   in Beclin-1.";
RL   EMBO J. 26:2527-2539(2007).
RN   [8]
RP   INTERACTION WITH HERPES SIMPLEX VIRUS 1 PROTEIN ICP34.5 (MICROBIAL
RP   INFECTION).
RX   PubMed=18005679; DOI=10.1016/j.chom.2006.12.001;
RA   Orvedahl A., Alexander D., Talloczy Z., Sun Q., Wei Y., Zhang W., Burns D.,
RA   Leib D.A., Levine B.;
RT   "HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy
RT   protein.";
RL   Cell Host Microbe 1:23-35(2007).
RN   [9]
RP   INTERACTION WITH ATG14; PIK3C3; PIK3R4 AND UVRAG.
RX   PubMed=18843052; DOI=10.1091/mbc.e08-01-0080;
RA   Itakura E., Kishi C., Inoue K., Mizushima N.;
RT   "Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with
RT   mammalian Atg14 and UVRAG.";
RL   Mol. Biol. Cell 19:5360-5372(2008).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH BCL2.
RX   PubMed=18570871; DOI=10.1016/j.molcel.2008.06.001;
RA   Wei Y., Pattingre S., Sinha S., Bassik M., Levine B.;
RT   "JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced
RT   autophagy.";
RL   Mol. Cell 30:678-688(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   INTERACTION WITH VMP1.
RX   PubMed=17724469; DOI=10.1038/sj.onc.1210743;
RA   Sauermann M., Sahin O., Sultmann H., Hahne F., Blaszkiewicz S., Majety M.,
RA   Zatloukal K., Fuzesi L., Poustka A., Wiemann S., Arlt D.;
RT   "Reduced expression of vacuole membrane protein 1 affects the invasion
RT   capacity of tumor cells.";
RL   Oncogene 27:1320-1326(2008).
RN   [13]
RP   INTERACTION WITH ATG14; PIK3C3 AND UVRAG, AND SUBCELLULAR LOCATION.
RX   PubMed=19050071; DOI=10.1073/pnas.0810452105;
RA   Sun Q., Fan W., Chen K., Ding X., Chen S., Zhong Q.;
RT   "Identification of Barkor as a mammalian autophagy-specific factor for
RT   Beclin 1 and class III phosphatidylinositol 3-kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:19211-19216(2008).
RN   [14]
RP   PHOSPHORYLATION AT THR-119, AND INTERACTION WITH DAPK1.
RX   PubMed=19180116; DOI=10.1038/embor.2008.246;
RA   Zalckvar E., Berissi H., Mizrachy L., Idelchuk Y., Koren I., Eisenstein M.,
RA   Sabanay H., Pinkas-Kramarski R., Kimchi A.;
RT   "DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes
RT   dissociation of beclin 1 from Bcl-XL and induction of autophagy.";
RL   EMBO Rep. 10:285-292(2009).
RN   [15]
RP   INTERACTION WITH HERPES SIMPLEX VIRUS 1 PROTEIN ICP34.5 (MICROBIAL
RP   INFECTION).
RX   PubMed=19759141; DOI=10.1128/jvi.01676-09;
RA   Leib D.A., Alexander D.E., Cox D., Yin J., Ferguson T.A.;
RT   "Interaction of ICP34.5 with Beclin 1 modulates herpes simplex virus type 1
RT   pathogenesis through control of CD4+ T-cell responses.";
RL   J. Virol. 83:12164-12171(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [17]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=20643123; DOI=10.1016/j.yexcr.2010.07.008;
RA   Thoresen S.B., Pedersen N.M., Liestol K., Stenmark H.;
RT   "A phosphatidylinositol 3-kinase class III sub-complex containing VPS15,
RT   VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and degradative
RT   endocytic traffic.";
RL   Exp. Cell Res. 316:3368-3378(2010).
RN   [18]
RP   INTERACTION WITH ATG14; RUBCN; PIK3C3; PIK3R4 AND UVRAG.
RX   PubMed=19270696; DOI=10.1038/ncb1846;
RA   Matsunaga K., Saitoh T., Tabata K., Omori H., Satoh T., Kurotori N.,
RA   Maejima I., Shirahama-Noda K., Ichimura T., Isobe T., Akira S., Noda T.,
RA   Yoshimori T.;
RT   "Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate
RT   autophagy at different stages.";
RL   Nat. Cell Biol. 11:385-396(2009).
RN   [19]
RP   FUNCTION, SUBCELLULAR LOCATION, PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF
RP   ASP-149.
RX   PubMed=19713971; DOI=10.1038/cdd.2009.121;
RA   Luo S., Rubinsztein D.C.;
RT   "Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect
RT   rescued by Bcl-xL.";
RL   Cell Death Differ. 17:268-277(2010).
RN   [20]
RP   FUNCTION, PROTEOLYTIC CLEAVAGE, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASP-133 AND ASP-149.
RX   PubMed=21364619; DOI=10.1038/cddis.2009.16;
RA   Wirawan E., Vande Walle L., Kersse K., Cornelis S., Claerhout S.,
RA   Vanoverberghe I., Roelandt R., De Rycke R., Verspurten J., Declercq W.,
RA   Agostinis P., Vanden Berghe T., Lippens S., Vandenabeele P.;
RT   "Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced
RT   autophagy and enhances apoptosis by promoting the release of proapoptotic
RT   factors from mitochondria.";
RL   Cell Death Dis. 1:E18-E18(2010).
RN   [21]
RP   INTERACTION WITH HMGB1.
RX   PubMed=20819940; DOI=10.1083/jcb.200911078;
RA   Tang D., Kang R., Livesey K.M., Cheh C.W., Farkas A., Loughran P.,
RA   Hoppe G., Bianchi M.E., Tracey K.J., Zeh H.J. III, Lotze M.T.;
RT   "Endogenous HMGB1 regulates autophagy.";
RL   J. Cell Biol. 190:881-892(2010).
RN   [22]
RP   FUNCTION.
RX   PubMed=20208530; DOI=10.1038/ncb2036;
RA   Sagona A.P., Nezis I.P., Pedersen N.M., Liestol K., Poulton J.,
RA   Rusten T.E., Skotheim R.I., Raiborg C., Stenmark H.;
RT   "PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of
RT   FYVE-CENT to the midbody.";
RL   Nat. Cell Biol. 12:362-371(2010).
RN   [23]
RP   PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF ASP-133 AND ASP-146.
RX   PubMed=21444671; DOI=10.1158/0008-5472.can-10-4475;
RA   Li H., Wang P., Sun Q., Ding W.X., Yin X.M., Sobol R.W., Stolz D.B., Yu J.,
RA   Zhang L.;
RT   "Following cytochrome c release, autophagy is inhibited during
RT   chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin
RT   1.";
RL   Cancer Res. 71:3625-3634(2011).
RN   [24]
RP   UBIQUITINATION, AND INTERACTION WITH USP10 AND USP13.
RX   PubMed=21962518; DOI=10.1016/j.cell.2011.08.037;
RA   Liu J., Xia H., Kim M., Xu L., Li Y., Zhang L., Cai Y., Norberg H.V.,
RA   Zhang T., Furuya T., Jin M., Zhu Z., Wang H., Yu J., Li Y., Hao Y.,
RA   Choi A., Ke H., Ma D., Yuan J.;
RT   "Beclin1 controls the levels of p53 by regulating the deubiquitination
RT   activity of USP10 and USP13.";
RL   Cell 147:223-234(2011).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH BCL2 AND AMBRA1.
RX   PubMed=21358617; DOI=10.1038/emboj.2011.49;
RA   Strappazzon F., Vietri-Rudan M., Campello S., Nazio F., Florenzano F.,
RA   Fimia G.M., Piacentini M., Levine B., Cecconi F.;
RT   "Mitochondrial BCL-2 inhibits AMBRA1-induced autophagy.";
RL   EMBO J. 30:1195-1208(2011).
RN   [26]
RP   INTERACTION WITH BCL2L10 AND BCL2L1, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF PHE-123.
RX   PubMed=22498477; DOI=10.4161/auto.19084;
RA   Robert G., Gastaldi C., Puissant A., Hamouda A., Jacquel A., Dufies M.,
RA   Belhacene N., Colosetti P., Reed J.C., Auberger P., Luciano F.;
RT   "The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic cell
RT   death.";
RL   Autophagy 8:637-649(2012).
RN   [27]
RP   UBIQUITINATION BY NEDD4, AND MUTAGENESIS OF TYR-352.
RX   PubMed=21936852; DOI=10.1042/bj20111424;
RA   Platta H.W., Abrahamsen H., Thoresen S.B., Stenmark H.;
RT   "Nedd4-dependent lysine-11-linked polyubiquitination of the tumour
RT   suppressor Beclin 1.";
RL   Biochem. J. 441:399-406(2012).
RN   [28]
RP   INTERACTION WITH SLAMF1.
RX   PubMed=22493499; DOI=10.1074/jbc.m112.367060;
RA   Ma C., Wang N., Detre C., Wang G., O'Keeffe M., Terhorst C.;
RT   "Receptor signaling lymphocyte-activation molecule family 1 (Slamf1)
RT   regulates membrane fusion and NADPH oxidase 2 (NOX2) activity by recruiting
RT   a Beclin-1/Vps34/ultraviolet radiation resistance-associated gene (UVRAG)
RT   complex.";
RL   J. Biol. Chem. 287:18359-18365(2012).
RN   [29]
RP   INTERACTION WITH HHV-5 PROTEIN TRS1 (MICROBIAL INFECTION).
RX   PubMed=22205736; DOI=10.1128/jvi.05746-11;
RA   Chaumorcel M., Lussignol M., Mouna L., Cavignac Y., Fahie K.,
RA   Cotte-Laffitte J., Geballe A., Brune W., Beau I., Codogno P., Esclatine A.;
RT   "The human cytomegalovirus protein TRS1 inhibits autophagy via its
RT   interaction with Beclin 1.";
RL   J. Virol. 86:2571-2584(2012).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [31]
RP   FUNCTION, INTERACTION WITH WASHC1, UBIQUITINATION AT LYS-437, AND
RP   MUTAGENESIS OF LYS-117 AND LYS-437.
RX   PubMed=23974797; DOI=10.1038/emboj.2013.189;
RA   Xia P., Wang S., Du Y., Zhao Z., Shi L., Sun L., Huang G., Ye B., Li C.,
RA   Dai Z., Hou N., Cheng X., Sun Q., Li L., Yang X., Fan Z.;
RT   "WASH inhibits autophagy through suppression of Beclin 1 ubiquitination.";
RL   EMBO J. 32:2685-2696(2013).
RN   [32]
RP   FUNCTION.
RX   PubMed=23184933; DOI=10.1074/jbc.m112.412783;
RA   Margariti A., Li H., Chen T., Martin D., Vizcay-Barrena G., Alam S.,
RA   Karamariti E., Xiao Q., Zampetaki A., Zhang Z., Wang W., Jiang Z., Gao C.,
RA   Ma B., Chen Y.G., Cockerill G., Hu Y., Xu Q., Zeng L.;
RT   "XBP1 mRNA splicing triggers an autophagic response in endothelial cells
RT   through BECLIN-1 transcriptional activation.";
RL   J. Biol. Chem. 288:859-872(2013).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [34]
RP   PHOSPHORYLATION AT SER-90 AND SER-93, MUTAGENESIS OF SER-90; SER-93 AND
RP   TRP-425, SUBCELLULAR LOCATION, MEMBRANE-SPANNING REGION, AND INTERACTION
RP   WITH PIK3C3; PIK3R4; UVRAG AND ATG14.
RX   PubMed=23878393; DOI=10.1128/mcb.00079-13;
RA   Fogel A.I., Dlouhy B.J., Wang C., Ryu S.W., Neutzner A., Hasson S.A.,
RA   Sideris D.P., Abeliovich H., Youle R.J.;
RT   "Role of membrane association and Atg14-dependent phosphorylation in
RT   beclin-1-mediated autophagy.";
RL   Mol. Cell. Biol. 33:3675-3688(2013).
RN   [35]
RP   INTERACTION WITH RAB39A.
RX   PubMed=24349490; DOI=10.1371/journal.pone.0083324;
RA   Seto S., Sugaya K., Tsujimura K., Nagata T., Horii T., Koide Y.;
RT   "Rab39a interacts with phosphatidylinositol 3-kinase and negatively
RT   regulates autophagy induced by lipopolysaccharide stimulation in
RT   macrophages.";
RL   PLoS ONE 8:E83324-E83324(2013).
RN   [36]
RP   INTERACTION WITH TRIM5.
RX   PubMed=25127057; DOI=10.1016/j.devcel.2014.06.013;
RA   Mandell M.A., Jain A., Arko-Mensah J., Chauhan S., Kimura T., Dinkins C.,
RA   Silvestri G., Munch J., Kirchhoff F., Simonsen A., Wei Y., Levine B.,
RA   Johansen T., Deretic V.;
RT   "TRIM proteins regulate autophagy and can target autophagic substrates by
RT   direct recognition.";
RL   Dev. Cell 30:394-409(2014).
RN   [37]
RP   FUNCTION.
RX   PubMed=25275521; DOI=10.1371/journal.pgen.1004626;
RA   McKnight N.C., Zhong Y., Wold M.S., Gong S., Phillips G.R., Dou Z.,
RA   Zhao Y., Heintz N., Zong W.X., Yue Z.;
RT   "Beclin 1 is required for neuron viability and regulates endosome pathways
RT   via the UVRAG-VPS34 complex.";
RL   PLoS Genet. 10:E1004626-E1004626(2014).
RN   [38]
RP   RECONSTITUTION OF THE PI3K COMPLEX I, AND ELECTRON MICROSCOPY OF THE PI3K
RP   COMPLEX I.
RX   PubMed=25490155; DOI=10.7554/elife.05115;
RA   Baskaran S., Carlson L.A., Stjepanovic G., Young L.N., Kim do J., Grob P.,
RA   Stanley R.E., Nogales E., Hurley J.H.;
RT   "Architecture and dynamics of the autophagic phosphatidylinositol 3-kinase
RT   complex.";
RL   Elife 3:0-0(2014).
RN   [39]
RP   INTERACTION WITH PPP2CA AND AMBRA1.
RX   PubMed=25803737; DOI=10.1080/15384101.2015.1021526;
RA   Cianfanelli V., D'Orazio M., Cecconi F.;
RT   "AMBRA1 and BECLIN 1 interplay in the crosstalk between autophagy and cell
RT   proliferation.";
RL   Cell Cycle 14:959-963(2015).
RN   [40]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-133 AND ASP-149.
RX   PubMed=26263979; DOI=10.3390/ijms160817611;
RA   Siddiqui M.A., Mukherjee S., Manivannan P., Malathi K.;
RT   "RNase L cleavage products promote switch from autophagy to apoptosis by
RT   caspase-mediated cleavage of beclin-1.";
RL   Int. J. Mol. Sci. 16:17611-17636(2015).
RN   [41]
RP   INTERACTION WITH MEFV; TRIM21 AND ULK1.
RX   PubMed=26347139; DOI=10.1083/jcb.201503023;
RA   Kimura T., Jain A., Choi S.W., Mandell M.A., Schroder K., Johansen T.,
RA   Deretic V.;
RT   "TRIM-mediated precision autophagy targets cytoplasmic regulators of innate
RT   immunity.";
RL   J. Cell Biol. 210:973-989(2015).
RN   [42]
RP   INTERACTION WITH IRGM, AND PHOSPHORYLATION AT SER-93 AND SER-96.
RX   PubMed=25891078; DOI=10.1016/j.molcel.2015.03.020;
RA   Chauhan S., Mandell M.A., Deretic V.;
RT   "IRGM governs the core autophagy machinery to conduct antimicrobial
RT   defense.";
RL   Mol. Cell 58:507-521(2015).
RN   [43]
RP   INTERACTION WITH TRIM16.
RX   PubMed=27693506; DOI=10.1016/j.devcel.2016.08.003;
RA   Chauhan S., Kumar S., Jain A., Ponpuak M., Mudd M.H., Kimura T., Choi S.W.,
RA   Peters R., Mandell M., Bruun J.A., Johansen T., Deretic V.;
RT   "TRIMs and Galectins Globally Cooperate and TRIM16 and Galectin-3 Co-direct
RT   Autophagy in Endomembrane Damage Homeostasis.";
RL   Dev. Cell 39:13-27(2016).
RN   [44]
RP   FUNCTION, AND INTERACTION WITH WDR81 AND WDR91.
RX   PubMed=26783301; DOI=10.1083/jcb.201506081;
RA   Liu K., Jian Y., Sun X., Yang C., Gao Z., Zhang Z., Liu X., Li Y., Xu J.,
RA   Jing Y., Mitani S., He S., Yang C.;
RT   "Negative regulation of phosphatidylinositol 3-phosphate levels in early-
RT   to-late endosome conversion.";
RL   J. Cell Biol. 212:181-198(2016).
RN   [45]
RP   INTERACTION WITH TRIM17.
RX   PubMed=27562068; DOI=10.1242/jcs.190017;
RA   Mandell M.A., Jain A., Kumar S., Castleman M.J., Anwar T., Eskelinen E.L.,
RA   Johansen T., Prekeris R., Deretic V.;
RT   "TRIM17 contributes to autophagy of midbodies while actively sparing other
RT   targets from degradation.";
RL   J. Cell Sci. 129:3562-3573(2016).
RN   [46]
RP   INTERACTION WITH LAPTM4B.
RX   PubMed=28479384; DOI=10.1016/j.gene.2017.05.006;
RA   Tian M., Chen Y., Tian D., Qiao X., Ma Z., Li J.;
RT   "Beclin1 antagonizes LAPTM4B-mediated EGFR overactivation in gastric cancer
RT   cells.";
RL   Gene 626:48-53(2017).
RN   [47]
RP   INTERACTION WITH ATXN3, UBIQUITINATION AT LYS-402, DEUBIQUITINATION BY
RP   ATXN3, MUTAGENESIS OF LYS-402, DOMAIN, AND FUNCTION.
RX   PubMed=28445460; DOI=10.1038/nature22078;
RA   Ashkenazi A., Bento C.F., Ricketts T., Vicinanza M., Siddiqi F., Pavel M.,
RA   Squitieri F., Hardenberg M.C., Imarisio S., Menzies F.M., Rubinsztein D.C.;
RT   "Polyglutamine tracts regulate beclin 1-dependent autophagy.";
RL   Nature 545:108-111(2017).
RN   [48]
RP   INTERACTION WITH TRIM50.
RX   PubMed=29604308; DOI=10.1016/j.bbamcr.2018.03.011;
RA   Fusco C., Mandriani B., Di Rienzo M., Micale L., Malerba N.,
RA   Cocciadiferro D., Sjoettem E., Augello B., Squeo G.M., Pellico M.T.,
RA   Jain A., Johansen T., Fimia G.M., Merla G.;
RT   "TRIM50 regulates Beclin 1 proautophagic activity.";
RL   Biochim. Biophys. Acta 1865:908-919(2018).
RN   [49]
RP   INTERACTION WITH ATG14.
RX   PubMed=31806350; DOI=10.1016/j.molcel.2019.10.035;
RA   Miao G., Zhang Y., Chen D., Zhang H.;
RT   "The ER-Localized Transmembrane Protein TMEM39A/SUSR2 Regulates Autophagy
RT   by Controlling the Trafficking of the PtdIns(4)P Phosphatase SAC1.";
RL   Mol. Cell 0:0-0(2019).
RN   [50]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=31123703; DOI=10.1126/sciadv.aau8857;
RA   Di Rienzo M., Antonioli M., Fusco C., Liu Y., Mari M., Orhon I., Refolo G.,
RA   Germani F., Corazzari M., Romagnoli A., Ciccosanti F., Mandriani B.,
RA   Pellico M.T., De La Torre R., Ding H., Dentice M., Neri M., Ferlini A.,
RA   Reggiori F., Kulesz-Martin M., Piacentini M., Merla G., Fimia G.M.;
RT   "Autophagy induction in atrophic muscle cells requires ULK1 activation by
RT   TRIM32 through unanchored K63-linked polyubiquitin chains.";
RL   Sci. Adv. 5:eaau8857-eaau8857(2019).
RN   [51]
RP   INTERACTION WITH SH3BGRL.
RX   PubMed=34870550; DOI=10.1080/15548627.2021.2002108;
RA   Zhang S., Liu X., Abdulmomen Ali Mohammed S., Li H., Cai W., Guan W.,
RA   Liu D., Wei Y., Rong D., Fang Y., Haider F., Lv H., Jin Z., Chen X., Mo Z.,
RA   Li L., Yang S., Wang H.;
RT   "Adaptor SH3BGRL drives autophagy-mediated chemoresistance through
RT   promoting PIK3C3 translation and ATG12 stability in breast cancers.";
RL   Autophagy 18:1-19(2021).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 107-135 IN COMPLEX WITH BCL2L1,
RP   AND DOMAIN BH3 MOTIF.
RX   PubMed=17337444; DOI=10.1074/jbc.m700492200;
RA   Oberstein A., Jeffrey P.D., Shi Y.;
RT   "Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a
RT   novel BH3-only protein.";
RL   J. Biol. Chem. 282:13123-13132(2007).
RN   [53]
RP   STRUCTURE BY NMR OF 106-128 IN COMPLEX WITH BCL2L1.
RX   PubMed=17659302; DOI=10.1016/j.jmb.2007.06.069;
RA   Feng W., Huang S., Wu H., Zhang M.;
RT   "Molecular basis of Bcl-xL's target recognition versatility revealed by the
RT   structure of Bcl-xL in complex with the BH3 domain of beclin-1.";
RL   J. Mol. Biol. 372:223-235(2007).
RN   [54]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 105-130 IN COMPLEX WITH MUHV-4 M11
RP   (MICROBIAL INFECTION), AND MUTAGENESIS OF LEU-112; LEU-116; GLY-120;
RP   ASP-121 AND PHE-123.
RX   PubMed=18797192; DOI=10.4161/auto.6803;
RA   Sinha S., Colbert C.L., Becker N., Wei Y., Levine B.;
RT   "Molecular basis of the regulation of Beclin 1-dependent autophagy by the
RT   gamma-herpesvirus 68 Bcl-2 homolog M11.";
RL   Autophagy 4:989-997(2008).
RN   [55]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 107-130 IN COMPLEX WITH MUHV-4 M11
RP   (MICROBIAL INFECTION), AND MUTAGENESIS OF LEU-112; LEU-116; LYS-117;
RP   GLY-120; ASP-121 AND PHE-123.
RX   PubMed=24443581; DOI=10.1074/jbc.m113.515361;
RA   Su M., Mei Y., Sanishvili R., Levine B., Colbert C.L., Sinha S.;
RT   "Targeting gamma-herpesvirus 68 Bcl-2-mediated down-regulation of
RT   autophagy.";
RL   J. Biol. Chem. 289:8029-8040(2014).
CC   -!- FUNCTION: Plays a central role in autophagy (PubMed:18570871,
CC       PubMed:21358617, PubMed:23184933, PubMed:23974797, PubMed:28445460).
CC       Acts as core subunit of the PI3K complex that mediates formation of
CC       phosphatidylinositol 3-phosphate; different complex forms are believed
CC       to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is
CC       involved in initiation of autophagosomes and PI3KC3-C2 in maturation of
CC       autophagosomes and endocytosis. Involved in regulation of degradative
CC       endocytic trafficking and required for the abcission step in
CC       cytokinesis, probably in the context of PI3KC3-C2 (PubMed:20643123,
CC       PubMed:20208530, PubMed:23974797, PubMed:26783301). Essential for the
CC       formation of PI3KC3-C2 but not PI3KC3-C1 PI3K complex forms. Involved
CC       in endocytosis (PubMed:25275521). Protects against infection by a
CC       neurovirulent strain of Sindbis virus (PubMed:9765397). May play a role
CC       in antiviral host defense. {ECO:0000269|PubMed:18570871,
CC       ECO:0000269|PubMed:20208530, ECO:0000269|PubMed:20643123,
CC       ECO:0000269|PubMed:21358617, ECO:0000269|PubMed:23184933,
CC       ECO:0000269|PubMed:23974797, ECO:0000269|PubMed:25275521,
CC       ECO:0000269|PubMed:26783301, ECO:0000269|PubMed:28445460,
CC       ECO:0000269|PubMed:9765397, ECO:0000305}.
CC   -!- FUNCTION: Beclin-1-C 35 kDa localized to mitochondria can promote
CC       apoptosis; it induces the mitochondrial translocation of BAX and the
CC       release of proapoptotic factors. {ECO:0000269|PubMed:21364619,
CC       ECO:0000269|PubMed:26263979}.
CC   -!- SUBUNIT: A homodimeric form is proposed to exist; this metastable form
CC       readily transits to ATG14- or UVRAG-containing complexes with
CC       BECN1:UVRAG being more stable than BECN1:ATG14 (By similarity).
CC       Component of the PI3K (PI3KC3/PI3K-III/class III phosphatidylinositol
CC       3-kinase) complex the core of which is composed of the catalytic
CC       subunit PIK3C3, the regulatory subunit PIK3R4 and BECN1 associating
CC       with additional regulatory/auxilliary subunits to form alternative
CC       complex forms. Alternative complex forms containing a forth regulatory
CC       subunit in a mutually exclusive manner are PI3K complex I (PI3KC3-C1)
CC       containing ATG14, and PI3K complex II (PI3KC3-C2) containing UVRAG.
CC       PI3KC3-C1 displays a V-shaped architecture with PIK3R4 serving as a
CC       bridge between PIK3C3 and the ATG14:BECN1 subcomplex (PubMed:18843052,
CC       PubMed:19050071, PubMed:19270696, PubMed:23878393, PubMed:25490155).
CC       Both, PI3KC3-C1 and PI3KC3-C2, can associate with further regulatory
CC       subunits, such as RUBCN, SH3GLB1/Bif-1 and AMBRA1 (PubMed:20643123,
CC       PubMed:19270696). PI3KC3-C1 probably associates with PIK3CB (By
CC       similarity). Interacts with AMBRA1, GOPC, GRID2 (PubMed:21358617).
CC       Forms a complex with PPP2CA and AMBRA1; AMBRA1 and BECN1 components of
CC       the complex regulate MYC stability via different pathways
CC       (PubMed:25803737). Interacts with BCL2 and BCL2L1 isoform Bcl-X(L); the
CC       interaction inhibits BECN1 function in promoting autophagy by
CC       interfering with the formation of the PI3K complex (PubMed:9765397,
CC       PubMed:16179260, PubMed:17446862, PubMed:18570871, PubMed:21358617,
CC       PubMed:22498477, PubMed:17337444, PubMed:17659302). Interacts with
CC       cytosolic HMGB1; inhibits the interaction of BECN1 and BCL2 leading to
CC       promotion of autophagy (PubMed:20819940). Interacts with USP10, USP13,
CC       VMP1, DAPK1, RAB39A (PubMed:19180116, PubMed:17724469, PubMed:17337444,
CC       PubMed:21962518, PubMed:24349490). Interacts with the poly-Gln domain
CC       of ATXN3; the interaction causes deubiquitination at Lys-402 and
CC       stabilizes BECN1 (PubMed:28445460). Interacts with SLAMF1
CC       (PubMed:22493499). Interacts with TRIM5; the interaction causes
CC       activation of BECN1 by causing its dissociation from its inhibitors
CC       BCL2 and TAB2 (PubMed:25127057). Interacts with active ULK1
CC       (phosphorylated on 'Ser-317') and MEFV simultaneously
CC       (PubMed:26347139). Interacts with WDR81 and WDR91; negatively regulates
CC       the PI3 kinase/PI3K activity associated with endosomal membranes
CC       (PubMed:26783301). Interacts with LAPTM4B; competes with EGFR for
CC       LAPTM4B binding; regulates EGFR activity (PubMed:28479384). Interacts
CC       with TRIM50 (PubMed:29604308). Interacts with TRIM16. Interacts with
CC       ATG14; this interaction is increased in the absence of TMEM39A
CC       (PubMed:31806350). Interacts with WASHC1; preventing interaction with
CC       AMBRA1 and the DCX(AMBRA1) complex and subsequent ubiquitination
CC       (PubMed:23974797). Interacts with TRIM17 (PubMed:27562068). Interacts
CC       with BCL2L10/BCL-B (via BH1 domain) (PubMed:22498477). Interacts with
CC       SH3BGRL (PubMed:34870550). Interacts with IRGM; enhancing BECN1-
CC       interacting partners and influencing the composition of the BECN1
CC       complex (PubMed:25891078). {ECO:0000250|UniProtKB:O88597,
CC       ECO:0000250|UniProtKB:Q91XJ1, ECO:0000269|PubMed:16179260,
CC       ECO:0000269|PubMed:17337444, ECO:0000269|PubMed:17446862,
CC       ECO:0000269|PubMed:17659302, ECO:0000269|PubMed:17724469,
CC       ECO:0000269|PubMed:18570871, ECO:0000269|PubMed:18797192,
CC       ECO:0000269|PubMed:18843052, ECO:0000269|PubMed:19050071,
CC       ECO:0000269|PubMed:19180116, ECO:0000269|PubMed:19270696,
CC       ECO:0000269|PubMed:20643123, ECO:0000269|PubMed:20819940,
CC       ECO:0000269|PubMed:21358617, ECO:0000269|PubMed:21962518,
CC       ECO:0000269|PubMed:22493499, ECO:0000269|PubMed:22498477,
CC       ECO:0000269|PubMed:23878393, ECO:0000269|PubMed:24349490,
CC       ECO:0000269|PubMed:24443581, ECO:0000269|PubMed:25127057,
CC       ECO:0000269|PubMed:25490155, ECO:0000269|PubMed:25803737,
CC       ECO:0000269|PubMed:25891078, ECO:0000269|PubMed:26347139,
CC       ECO:0000269|PubMed:26783301, ECO:0000269|PubMed:27562068,
CC       ECO:0000269|PubMed:27693506, ECO:0000269|PubMed:28445460,
CC       ECO:0000269|PubMed:28479384, ECO:0000269|PubMed:29604308,
CC       ECO:0000269|PubMed:31806350, ECO:0000269|PubMed:34870550,
CC       ECO:0000269|PubMed:9765397, ECO:0000305}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human
CC       cytomegalovirus/HHV-5 protein TRS1. {ECO:0000269|PubMed:22205736}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with murine gammaherpesvirus
CC       68 M11. {ECO:0000269|PubMed:18797192, ECO:0000269|PubMed:24443581}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes simplex virus 1
CC       (HHV-1) protein ICP34.5; this interaction antagonizes the host
CC       autophagy response. {ECO:0000269|PubMed:18005679,
CC       ECO:0000269|PubMed:19759141}.
CC   -!- INTERACTION:
CC       Q14457; Q9C0C7: AMBRA1; NbExp=9; IntAct=EBI-949378, EBI-2512975;
CC       Q14457; Q6ZNE5: ATG14; NbExp=47; IntAct=EBI-949378, EBI-2690371;
CC       Q14457; P54253: ATXN1; NbExp=6; IntAct=EBI-949378, EBI-930964;
CC       Q14457; P54252-1: ATXN3; NbExp=10; IntAct=EBI-949378, EBI-946068;
CC       Q14457; P46379-2: BAG6; NbExp=3; IntAct=EBI-949378, EBI-10988864;
CC       Q14457; P10415: BCL2; NbExp=18; IntAct=EBI-949378, EBI-77694;
CC       Q14457; Q07817-1: BCL2L1; NbExp=5; IntAct=EBI-949378, EBI-287195;
CC       Q14457; O15392: BIRC5; NbExp=3; IntAct=EBI-949378, EBI-518823;
CC       Q14457; P38398-6: BRCA1; NbExp=3; IntAct=EBI-949378, EBI-25833510;
CC       Q14457; P48643: CCT5; NbExp=3; IntAct=EBI-949378, EBI-355710;
CC       Q14457; Q96A83-2: COL26A1; NbExp=3; IntAct=EBI-949378, EBI-21553822;
CC       Q14457; P53355: DAPK1; NbExp=4; IntAct=EBI-949378, EBI-358616;
CC       Q14457; O75190-2: DNAJB6; NbExp=3; IntAct=EBI-949378, EBI-12593112;
CC       Q14457; O14645: DNALI1; NbExp=3; IntAct=EBI-949378, EBI-395638;
CC       Q14457; P00533: EGFR; NbExp=7; IntAct=EBI-949378, EBI-297353;
CC       Q14457; Q8IYI6: EXOC8; NbExp=4; IntAct=EBI-949378, EBI-742102;
CC       Q14457; P15311: EZR; NbExp=3; IntAct=EBI-949378, EBI-1056902;
CC       Q14457; P21333-2: FLNA; NbExp=3; IntAct=EBI-949378, EBI-9641086;
CC       Q14457; P01100: FOS; NbExp=3; IntAct=EBI-949378, EBI-852851;
CC       Q14457; P50440: GATM; NbExp=3; IntAct=EBI-949378, EBI-2552594;
CC       Q14457; P62993: GRB2; NbExp=3; IntAct=EBI-949378, EBI-401755;
CC       Q14457; P42261: GRIA1; NbExp=3; IntAct=EBI-949378, EBI-6980805;
CC       Q14457; P28799: GRN; NbExp=3; IntAct=EBI-949378, EBI-747754;
CC       Q14457; P09429: HMGB1; NbExp=2; IntAct=EBI-949378, EBI-389432;
CC       Q14457; P04792: HSPB1; NbExp=3; IntAct=EBI-949378, EBI-352682;
CC       Q14457; P42858: HTT; NbExp=14; IntAct=EBI-949378, EBI-466029;
CC       Q14457; O60333-2: KIF1B; NbExp=3; IntAct=EBI-949378, EBI-10975473;
CC       Q14457; O14901: KLF11; NbExp=3; IntAct=EBI-949378, EBI-948266;
CC       Q14457; P05783: KRT18; NbExp=2; IntAct=EBI-949378, EBI-297888;
CC       Q14457; Q13449: LSAMP; NbExp=3; IntAct=EBI-949378, EBI-4314821;
CC       Q14457; Q07820: MCL1; NbExp=2; IntAct=EBI-949378, EBI-1003422;
CC       Q14457; Q9UBU9: NXF1; NbExp=3; IntAct=EBI-949378, EBI-398874;
CC       Q14457; Q8N2W9: PIAS4; NbExp=3; IntAct=EBI-949378, EBI-473160;
CC       Q14457; Q8NEB9: PIK3C3; NbExp=39; IntAct=EBI-949378, EBI-1056470;
CC       Q14457; Q16512: PKN1; NbExp=3; IntAct=EBI-949378, EBI-602382;
CC       Q14457; P60891: PRPS1; NbExp=3; IntAct=EBI-949378, EBI-749195;
CC       Q14457; Q14964: RAB39A; NbExp=2; IntAct=EBI-949378, EBI-3048577;
CC       Q14457; P63000: RAC1; NbExp=3; IntAct=EBI-949378, EBI-413628;
CC       Q14457; P10276-2: RARA; NbExp=3; IntAct=EBI-949378, EBI-10197061;
CC       Q14457; Q9Y3C5: RNF11; NbExp=3; IntAct=EBI-949378, EBI-396669;
CC       Q14457; Q92622: RUBCN; NbExp=15; IntAct=EBI-949378, EBI-2952709;
CC       Q14457; Q9H714-3: RUBCNL; NbExp=3; IntAct=EBI-949378, EBI-9088146;
CC       Q14457; Q96ES7: SGF29; NbExp=3; IntAct=EBI-949378, EBI-743117;
CC       Q14457; P14678-2: SNRPB; NbExp=3; IntAct=EBI-949378, EBI-372475;
CC       Q14457; P12931: SRC; NbExp=3; IntAct=EBI-949378, EBI-621482;
CC       Q14457; Q9NYJ8: TAB2; NbExp=11; IntAct=EBI-949378, EBI-358708;
CC       Q14457; Q8N5C8: TAB3; NbExp=9; IntAct=EBI-949378, EBI-359964;
CC       Q14457; P17752: TPH1; NbExp=3; IntAct=EBI-949378, EBI-3956833;
CC       Q14457; Q13885: TUBB2A; NbExp=3; IntAct=EBI-949378, EBI-711595;
CC       Q14457; P14679-2: TYR; NbExp=3; IntAct=EBI-949378, EBI-25894402;
CC       Q14457; P14927: UQCRB; NbExp=3; IntAct=EBI-949378, EBI-743128;
CC       Q14457; P31930: UQCRC1; NbExp=3; IntAct=EBI-949378, EBI-1052596;
CC       Q14457; Q9P2Y5: UVRAG; NbExp=45; IntAct=EBI-949378, EBI-2952704;
CC       Q14457; P61758: VBP1; NbExp=3; IntAct=EBI-949378, EBI-357430;
CC       Q14457; P08670: VIM; NbExp=3; IntAct=EBI-949378, EBI-353844;
CC       Q14457; Q96GC9: VMP1; NbExp=3; IntAct=EBI-949378, EBI-2800296;
CC       Q14457; A8K0Z3: WASHC1; NbExp=3; IntAct=EBI-949378, EBI-6160405;
CC       Q14457; O76024: WFS1; NbExp=3; IntAct=EBI-949378, EBI-720609;
CC       Q14457; O95229: ZWINT; NbExp=6; IntAct=EBI-949378, EBI-1001132;
CC       Q14457; Q2GJL5: ats-1; Xeno; NbExp=4; IntAct=EBI-949378, EBI-16025394;
CC       Q14457; P03407: nef; Xeno; NbExp=2; IntAct=EBI-949378, EBI-7355020;
CC       Q14457; PRO_0000283876 [P0C6X5]: rep; Xeno; NbExp=3; IntAct=EBI-949378, EBI-25622115;
CC       Q14457; Q9QUM4: Slamf1; Xeno; NbExp=8; IntAct=EBI-949378, EBI-7910086;
CC       Q14457; P89884: vBCL2; Xeno; NbExp=4; IntAct=EBI-949378, EBI-8849581;
CC       Q14457; Q91ZQ0: Vmp1; Xeno; NbExp=6; IntAct=EBI-949378, EBI-11163586;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19713971,
CC       ECO:0000269|PubMed:21364619, ECO:0000269|PubMed:22498477}. Golgi
CC       apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:19050071};
CC       Peripheral membrane protein {ECO:0000269|PubMed:19050071}. Endosome
CC       membrane {ECO:0000269|PubMed:23878393}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:23878393}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:23878393}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:23878393}. Mitochondrion membrane
CC       {ECO:0000269|PubMed:23878393}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:23878393}. Endosome {ECO:0000250|UniProtKB:O88597}.
CC       Cytoplasmic vesicle, autophagosome {ECO:0000305}. Note=Interaction with
CC       ATG14 promotes translocation to autophagosomes. Expressed in dendrites
CC       and cell bodies of cerebellar Purkinje cells (By similarity).
CC       {ECO:0000250|UniProtKB:O88597, ECO:0000269|PubMed:19050071}.
CC   -!- SUBCELLULAR LOCATION: [Beclin-1-C 35 kDa]: Mitochondrion
CC       {ECO:0000269|PubMed:21364619, ECO:0000269|PubMed:26263979}. Nucleus
CC       {ECO:0000269|PubMed:19713971}. Cytoplasm {ECO:0000269|PubMed:19713971}.
CC   -!- SUBCELLULAR LOCATION: [Beclin-1-C 37 kDa]: Mitochondrion
CC       {ECO:0000250|UniProtKB:O88597}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The coiled coil domain can form antiparallel homodimers and
CC       mediates dimerization with the coiled coil domains of ATG14 or UVRAG
CC       involved in the formation of PI3K complexes.
CC       {ECO:0000250|UniProtKB:Q91XJ1}.
CC   -!- DOMAIN: The C-terminal evolutionary conserved domain (ECD) contains
CC       poly-Gln-binding domains such as the ATXN3 poly-Gln motif, consistent
CC       with structural docking models revealing two highly scored poly-Gln-
CC       binding pockets in the ECD (PubMed:28445460). As some binding is
CC       observed with BECN1 lacking the ECD, other domains of BECN1 may also
CC       interact with ATXN3 (PubMed:28445460). {ECO:0000269|PubMed:28445460}.
CC   -!- PTM: Phosphorylation at Thr-119 by DAPK1 reduces its interaction with
CC       BCL2 and BCL2L1 and promotes induction of autophagy (PubMed:19180116).
CC       In response to autophagic stimuli, phosphorylated at serine residues by
CC       AMPK in an ATG14-dependent manner, and this phosphorylation is critical
CC       for maximally efficient autophagy (PubMed:23878393, PubMed:25891078).
CC       {ECO:0000269|PubMed:19180116, ECO:0000269|PubMed:23878393,
CC       ECO:0000269|PubMed:25891078}.
CC   -!- PTM: Polyubiquitinated by NEDD4, both with 'Lys-11'- and 'Lys-63'-
CC       linkages (PubMed:21936852). 'Lys-11'-linked polyubiquitination leads to
CC       degradation and is enhanced when the stabilizing interaction partner
CC       VPS34 is depleted (PubMed:21936852). Deubiquitinated by USP10 and
CC       USP13, leading to stabilize the PIK3C3/VPS34-containing complexes
CC       (PubMed:21962518). Polyubiquitinated at Lys-402 with 'Lys-48'-linkages
CC       (PubMed:28445460). 'Lys-48'-linked polyubiquitination of Lys-402 leads
CC       to degradation (PubMed:28445460). Deubiquitinated by ATXN3, leading to
CC       stabilization (PubMed:28445460). Ubiquitinated at Lys-437 via 'Lys-63'-
CC       linkage by the DCX(AMBRA1) complex, thereby increasing the association
CC       between BECN1 and PIK3C3 to promote PIK3C3 activity (PubMed:23974797).
CC       {ECO:0000269|PubMed:21936852, ECO:0000269|PubMed:21962518,
CC       ECO:0000269|PubMed:23974797, ECO:0000269|PubMed:28445460}.
CC   -!- PTM: Proteolytically processed by caspases including CASP8 and CASP3;
CC       the C-terminal fragments lack autophagy-inducing capacity and are
CC       proposed to induce apoptosis. Thus the cleavage is proposed to be an
CC       determinant to switch from autophagy to apoptosis pathways affecting
CC       cellular homeostasis including viral infections and survival of tumor
CC       cells. {ECO:0000305|PubMed:19713971, ECO:0000305|PubMed:21364619}.
CC   -!- MISCELLANEOUS: Expanded poly-Gln tracts inhibit ATXN3-BECN1
CC       interaction, decrease BECN1 levels and impair starvation-induced
CC       autophagy (PubMed:28445460). {ECO:0000269|PubMed:28445460}.
CC   -!- SIMILARITY: Belongs to the beclin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF077301; AAC68653.1; -; mRNA.
DR   EMBL; AF139131; AAD27650.1; -; mRNA.
DR   EMBL; AK312651; BAG35534.1; -; mRNA.
DR   EMBL; BC010276; AAH10276.1; -; mRNA.
DR   EMBL; L38932; AAB59573.1; -; mRNA.
DR   CCDS; CCDS11441.1; -.
DR   PIR; I54209; I54209.
DR   RefSeq; NP_001300927.1; NM_001313998.1.
DR   RefSeq; NP_001300928.1; NM_001313999.1.
DR   RefSeq; NP_001300929.1; NM_001314000.1.
DR   RefSeq; NP_003757.1; NM_003766.4.
DR   PDB; 2P1L; X-ray; 2.50 A; B/D/F/H=107-135.
DR   PDB; 2PON; NMR; -; A=106-128.
DR   PDB; 3DVU; X-ray; 2.50 A; C/D=105-130.
DR   PDB; 4DDP; X-ray; 1.55 A; A=241-450.
DR   PDB; 4MI8; X-ray; 2.10 A; C/D=107-130.
DR   PDB; 5EFM; X-ray; 1.95 A; A=141-171.
DR   PDB; 5HHE; X-ray; 1.46 A; A/D=175-265.
DR   PDB; 5VAU; X-ray; 1.75 A; E/F/G/H=105-130.
DR   PDB; 5VAX; X-ray; 2.00 A; E/F/G/H=105-130.
DR   PDB; 5VAY; X-ray; 1.80 A; E/F/G/H=105-130.
DR   PDB; 6DCN; X-ray; 2.44 A; C/D=105-130.
DR   PDB; 6DCO; X-ray; 2.20 A; C/D=105-130.
DR   PDB; 6HOI; X-ray; 1.14 A; F/G=93-102.
DR   PDB; 6HOJ; X-ray; 1.51 A; A/B/C=93-105.
DR   PDB; 6HOK; X-ray; 1.61 A; A=93-105.
DR   PDB; 7BL1; EM; 9.80 A; EEE=1-450.
DR   PDBsum; 2P1L; -.
DR   PDBsum; 2PON; -.
DR   PDBsum; 3DVU; -.
DR   PDBsum; 4DDP; -.
DR   PDBsum; 4MI8; -.
DR   PDBsum; 5EFM; -.
DR   PDBsum; 5HHE; -.
DR   PDBsum; 5VAU; -.
DR   PDBsum; 5VAX; -.
DR   PDBsum; 5VAY; -.
DR   PDBsum; 6DCN; -.
DR   PDBsum; 6DCO; -.
DR   PDBsum; 6HOI; -.
DR   PDBsum; 6HOJ; -.
DR   PDBsum; 6HOK; -.
DR   PDBsum; 7BL1; -.
DR   AlphaFoldDB; Q14457; -.
DR   SMR; Q14457; -.
DR   BioGRID; 114226; 199.
DR   ComplexPortal; CPX-73; Phosphatidylinositol 3-kinase complex, class III, ATG14 variant.
DR   ComplexPortal; CPX-74; Phosphatidylinositol 3-kinase complex, class III, UVRAG variant.
DR   CORUM; Q14457; -.
DR   DIP; DIP-44611N; -.
DR   ELM; Q14457; -.
DR   IntAct; Q14457; 154.
DR   MINT; Q14457; -.
DR   STRING; 9606.ENSP00000355231; -.
DR   ChEMBL; CHEMBL4296010; -.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB13952; Estradiol acetate.
DR   DrugBank; DB13953; Estradiol benzoate.
DR   DrugBank; DB13954; Estradiol cypionate.
DR   DrugBank; DB13955; Estradiol dienanthate.
DR   DrugBank; DB13956; Estradiol valerate.
DR   MoonDB; Q14457; Predicted.
DR   TCDB; 9.A.15.2.1; the autophagy-related phagophore-formation transporter (apt) family.
DR   GlyGen; Q14457; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q14457; -.
DR   PhosphoSitePlus; Q14457; -.
DR   BioMuta; BECN1; -.
DR   DMDM; 13124704; -.
DR   EPD; Q14457; -.
DR   jPOST; Q14457; -.
DR   MassIVE; Q14457; -.
DR   MaxQB; Q14457; -.
DR   PaxDb; Q14457; -.
DR   PeptideAtlas; Q14457; -.
DR   ProteomicsDB; 59999; -.
DR   Antibodypedia; 4116; 1789 antibodies from 47 providers.
DR   DNASU; 8678; -.
DR   Ensembl; ENST00000361523.8; ENSP00000355231.3; ENSG00000126581.13.
DR   Ensembl; ENST00000590099.6; ENSP00000465364.1; ENSG00000126581.13.
DR   GeneID; 8678; -.
DR   KEGG; hsa:8678; -.
DR   MANE-Select; ENST00000590099.6; ENSP00000465364.1; NM_001313998.2; NP_001300927.1.
DR   UCSC; uc002ibn.3; human.
DR   AGR; HGNC:1034; -.
DR   CTD; 8678; -.
DR   DisGeNET; 8678; -.
DR   GeneCards; BECN1; -.
DR   HGNC; HGNC:1034; BECN1.
DR   HPA; ENSG00000126581; Low tissue specificity.
DR   MIM; 604378; gene.
DR   neXtProt; NX_Q14457; -.
DR   OpenTargets; ENSG00000126581; -.
DR   PharmGKB; PA25337; -.
DR   VEuPathDB; HostDB:ENSG00000126581; -.
DR   eggNOG; KOG2751; Eukaryota.
DR   GeneTree; ENSGT00390000008164; -.
DR   HOGENOM; CLU_024219_4_1_1; -.
DR   InParanoid; Q14457; -.
DR   OMA; DTFCIGH; -.
DR   OrthoDB; 11439at2759; -.
DR   PhylomeDB; Q14457; -.
DR   TreeFam; TF314282; -.
DR   PathwayCommons; Q14457; -.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-9679504; Translation of Replicase and Assembly of the Replication Transcription Complex.
DR   Reactome; R-HSA-9694676; Translation of Replicase and Assembly of the Replication Transcription Complex.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   SignaLink; Q14457; -.
DR   SIGNOR; Q14457; -.
DR   BioGRID-ORCS; 8678; 88 hits in 1172 CRISPR screens.
DR   ChiTaRS; BECN1; human.
DR   EvolutionaryTrace; Q14457; -.
DR   GeneWiki; BECN1; -.
DR   GenomeRNAi; 8678; -.
DR   Pharos; Q14457; Tbio.
DR   PRO; PR:Q14457; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q14457; protein.
DR   Bgee; ENSG00000126581; Expressed in rectum and 206 other tissues.
DR   ExpressionAtlas; Q14457; baseline and differential.
DR   Genevisible; Q14457; HS.
DR   GO; GO:0005776; C:autophagosome; ISS:UniProt.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0032473; C:cytoplasmic side of mitochondrial outer membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0045335; C:phagocytic vesicle; IEA:Ensembl.
DR   GO; GO:0000407; C:phagophore assembly site; IBA:GO_Central.
DR   GO; GO:0035032; C:phosphatidylinositol 3-kinase complex, class III; IPI:ComplexPortal.
DR   GO; GO:0034271; C:phosphatidylinositol 3-kinase complex, class III, type I; IBA:GO_Central.
DR   GO; GO:0034272; C:phosphatidylinositol 3-kinase complex, class III, type II; IBA:GO_Central.
DR   GO; GO:0005802; C:trans-Golgi network; IEA:Ensembl.
DR   GO; GO:0051020; F:GTPase binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IDA:UniProt.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0050435; P:amyloid-beta metabolic process; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0000045; P:autophagosome assembly; ISS:UniProtKB.
DR   GO; GO:0097352; P:autophagosome maturation; IDA:ComplexPortal.
DR   GO; GO:0006914; P:autophagy; IDA:CAFA.
DR   GO; GO:0000422; P:autophagy of mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0071275; P:cellular response to aluminum ion; IEA:Ensembl.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IEA:Ensembl.
DR   GO; GO:0071280; P:cellular response to copper ion; IEA:Ensembl.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0042149; P:cellular response to glucose starvation; ISS:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0006995; P:cellular response to nitrogen starvation; IBA:GO_Central.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045022; P:early endosome to late endosome transport; IDA:ComplexPortal.
DR   GO; GO:0043652; P:engulfment of apoptotic cell; IEA:Ensembl.
DR   GO; GO:0045324; P:late endosome to vacuole transport; IBA:GO_Central.
DR   GO; GO:0007040; P:lysosome organization; IEA:Ensembl.
DR   GO; GO:0016236; P:macroautophagy; ISS:UniProtKB.
DR   GO; GO:0000423; P:mitophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0007080; P:mitotic metaphase plate congression; IMP:CACAO.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc.
DR   GO; GO:1902902; P:negative regulation of autophagosome assembly; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:1905672; P:negative regulation of lysosome organization; IEA:Ensembl.
DR   GO; GO:0043069; P:negative regulation of programmed cell death; IMP:MGI.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; IDA:ComplexPortal.
DR   GO; GO:1902425; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; IMP:CACAO.
DR   GO; GO:2000786; P:positive regulation of autophagosome assembly; IEA:Ensembl.
DR   GO; GO:0010508; P:positive regulation of autophagy; IDA:UniProtKB.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IEA:Ensembl.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:ComplexPortal.
DR   GO; GO:0006622; P:protein targeting to lysosome; NAS:ComplexPortal.
DR   GO; GO:0065003; P:protein-containing complex assembly; IDA:UniProt.
DR   GO; GO:0032801; P:receptor catabolic process; IMP:UniProtKB.
DR   GO; GO:0010506; P:regulation of autophagy; IDA:ComplexPortal.
DR   GO; GO:0050790; P:regulation of catalytic activity; IEA:Ensembl.
DR   GO; GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0016241; P:regulation of macroautophagy; IDA:ComplexPortal.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0010040; P:response to iron(II) ion; IEA:Ensembl.
DR   GO; GO:0010288; P:response to lead ion; IEA:Ensembl.
DR   GO; GO:0098780; P:response to mitochondrial depolarisation; IMP:BHF-UCL.
DR   GO; GO:0033197; P:response to vitamin E; IEA:Ensembl.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl.
DR   GO; GO:0061912; P:selective autophagy; IMP:DisProt.
DR   GO; GO:0039521; P:suppression by virus of host autophagy; IDA:DisProt.
DR   DisProt; DP01149; -.
DR   Gene3D; 6.10.250.3110; -; 1.
DR   Gene3D; 1.10.418.40; Autophagy protein 6/Beclin 1; 1.
DR   IDEAL; IID00669; -.
DR   InterPro; IPR007243; Atg6/Beclin.
DR   InterPro; IPR038274; Atg6/Beclin_C_sf.
DR   InterPro; IPR041691; Atg6/beclin_CC.
DR   InterPro; IPR040455; Atg6_BARA.
DR   InterPro; IPR029318; BH3_dom.
DR   PANTHER; PTHR12768; BECLIN 1; 1.
DR   PANTHER; PTHR12768:SF6; BECLIN-1; 1.
DR   Pfam; PF04111; APG6; 1.
DR   Pfam; PF17675; APG6_N; 1.
DR   Pfam; PF15285; BH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antiviral defense; Apoptosis; Autophagy;
KW   Cell cycle; Cell division; Coiled coil; Cytoplasm; Cytoplasmic vesicle;
KW   Endocytosis; Endoplasmic reticulum; Endosome; Golgi apparatus;
KW   Host-virus interaction; Isopeptide bond; Membrane; Mitochondrion; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..450
FT                   /note="Beclin-1"
FT                   /id="PRO_0000218555"
FT   CHAIN           134..450
FT                   /note="Beclin-1-C 37 kDa"
FT                   /evidence="ECO:0000305|PubMed:21364619"
FT                   /id="PRO_0000435036"
FT   CHAIN           150..450
FT                   /note="Beclin-1-C 35 kDa"
FT                   /evidence="ECO:0000305|PubMed:21364619,
FT                   ECO:0000305|PubMed:26263979"
FT                   /id="PRO_0000435037"
FT   REGION          48..72
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          112..159
FT                   /note="Interaction with BCL2 and BCL2L1 isoform Bcl-X(L)"
FT                   /evidence="ECO:0000269|PubMed:17446862"
FT   REGION          245..450
FT                   /note="Evolutionary conserved domain (ECD)"
FT                   /evidence="ECO:0000305|PubMed:28445460"
FT   REGION          425..450
FT                   /note="Required for membrane-association"
FT                   /evidence="ECO:0000269|PubMed:23878393"
FT   COILED          142..270
FT                   /evidence="ECO:0000255"
FT   MOTIF           108..127
FT                   /note="BH3"
FT                   /evidence="ECO:0000269|PubMed:17337444"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:31123703"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         90
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:23878393"
FT   MOD_RES         93
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:23878393,
FT                   ECO:0000269|PubMed:25891078"
FT   MOD_RES         96
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:25891078"
FT   MOD_RES         119
FT                   /note="Phosphothreonine; by DAPK1"
FT                   /evidence="ECO:0000269|PubMed:19180116"
FT   CROSSLNK        402
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:28445460"
FT   CROSSLNK        437
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23974797"
FT   VARIANT         103
FT                   /note="A -> V"
FT                   /id="VAR_010384"
FT   VARIANT         403
FT                   /note="I -> T"
FT                   /id="VAR_005236"
FT   MUTAGEN         90
FT                   /note="S->A: Complete loss of phosphorylation. Complete
FT                   loss of phosphorylation and defective autophagic function;
FT                   when associated with Ala-93."
FT                   /evidence="ECO:0000269|PubMed:23878393"
FT   MUTAGEN         93
FT                   /note="S->A: Partial loss of phosphorylation. Complete loss
FT                   of phosphorylation and defective autophagic function; when
FT                   associated with Ala-90."
FT                   /evidence="ECO:0000269|PubMed:23878393"
FT   MUTAGEN         112
FT                   /note="L->A: Weakly decreases interaction with MUHV-4 M11,
FT                   greatly decreases interaction with BCL2L1 isoform
FT                   Bcl-X(L)."
FT                   /evidence="ECO:0000269|PubMed:18797192,
FT                   ECO:0000269|PubMed:24443581"
FT   MUTAGEN         116
FT                   /note="L->A: Decreases interaction with BCL2L1 isoform
FT                   Bcl-X(L)."
FT                   /evidence="ECO:0000269|PubMed:17446862,
FT                   ECO:0000269|PubMed:18797192, ECO:0000269|PubMed:24443581"
FT   MUTAGEN         117
FT                   /note="K->A: Weakly decreases interaction with MUHV-4 M11,
FT                   greatly decreases interaction with BCL2L1 isoform
FT                   Bcl-X(L)."
FT                   /evidence="ECO:0000269|PubMed:24443581"
FT   MUTAGEN         117
FT                   /note="K->R: Does not affect ubiquitination by the
FT                   DCX(AMBRA1) complex."
FT                   /evidence="ECO:0000269|PubMed:23974797"
FT   MUTAGEN         120..121
FT                   /note="GD->EA: Weakly decreases interaction with MUHV-4
FT                   M11, disrupts interaction with BCL2L1 isoform Bcl-X(L)."
FT                   /evidence="ECO:0000269|PubMed:24443581"
FT   MUTAGEN         120
FT                   /note="G->E: Decreases interaction with MUHV-4 M11,
FT                   disrupts interaction with BCL2L1 isoform Bcl-X(L)."
FT                   /evidence="ECO:0000269|PubMed:24443581"
FT   MUTAGEN         121
FT                   /note="D->A: No effect on interaction with MUHV-4 M11,
FT                   disrupts interaction with BCL2L1 isoform Bcl-X(L)."
FT                   /evidence="ECO:0000269|PubMed:24443581"
FT   MUTAGEN         123
FT                   /note="F->A: Weakly decreases interaction with MUHV-4 M11,
FT                   disrupts interaction with BCL2 and decreases interaction
FT                   with BCL2L1 isoform Bcl-X(L). Reduces interaction with
FT                   BCL2L10."
FT                   /evidence="ECO:0000269|PubMed:16179260,
FT                   ECO:0000269|PubMed:17446862, ECO:0000269|PubMed:18797192,
FT                   ECO:0000269|PubMed:22498477, ECO:0000269|PubMed:24443581"
FT   MUTAGEN         133
FT                   /note="D->A: Abolishes in vitro cleavage by CASP3 and
FT                   CASP8; when associated with A-149."
FT                   /evidence="ECO:0000269|PubMed:21364619"
FT   MUTAGEN         133
FT                   /note="D->A: Abolishes in vitro cleavage by CASP8; when
FT                   associated with A-146."
FT                   /evidence="ECO:0000269|PubMed:21444671"
FT   MUTAGEN         146
FT                   /note="D->A: Abolishes in vitro cleavage by CASP8; when
FT                   associated with A-133."
FT                   /evidence="ECO:0000269|PubMed:21444671"
FT   MUTAGEN         149
FT                   /note="D->A: Abolishes in vitro cleavage by CASP3 and
FT                   CASP8; when associated with A-133."
FT                   /evidence="ECO:0000269|PubMed:21364619"
FT   MUTAGEN         149
FT                   /note="D->E: Abolishes in vitro cleavage by CASP3."
FT                   /evidence="ECO:0000269|PubMed:19713971"
FT   MUTAGEN         352
FT                   /note="Y->A: Significantly reduces ubiquitination."
FT                   /evidence="ECO:0000269|PubMed:21936852"
FT   MUTAGEN         402
FT                   /note="K->R: Decreases K48 polyubiquitination and
FT                   stabilizes BECN1."
FT                   /evidence="ECO:0000269|PubMed:28445460"
FT   MUTAGEN         425
FT                   /note="W->A: Decrease in membrane-association."
FT                   /evidence="ECO:0000269|PubMed:23878393"
FT   MUTAGEN         437
FT                   /note="K->R: Abolished ubiquitination by the DCX(AMBRA1)
FT                   complex."
FT                   /evidence="ECO:0000269|PubMed:23974797"
FT   CONFLICT        150
FT                   /note="T -> A (in Ref. 5; AAB59573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        161
FT                   /note="N -> S (in Ref. 3; BAG35534)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        314
FT                   /note="L -> H (in Ref. 3; BAG35534)"
FT                   /evidence="ECO:0000305"
FT   HELIX           110..127
FT                   /evidence="ECO:0007829|PDB:5VAU"
FT   HELIX           160..169
FT                   /evidence="ECO:0007829|PDB:5EFM"
FT   HELIX           176..265
FT                   /evidence="ECO:0007829|PDB:5HHE"
FT   STRAND          276..279
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   STRAND          282..285
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   HELIX           300..321
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   STRAND          326..331
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   HELIX           334..336
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   STRAND          338..343
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   STRAND          349..351
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   HELIX           358..360
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   HELIX           364..384
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   TURN            398..401
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   STRAND          402..404
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   TURN            406..409
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   STRAND          412..415
FT                   /evidence="ECO:0007829|PDB:4DDP"
FT   HELIX           422..446
FT                   /evidence="ECO:0007829|PDB:4DDP"
SQ   SEQUENCE   450 AA;  51896 MW;  ABF0C2DD7087473C CRC64;
     MEGSKTSNNS TMQVSFVCQR CSQPLKLDTS FKILDRVTIQ ELTAPLLTTA QAKPGETQEE
     ETNSGEEPFI ETPRQDGVSR RFIPPARMMS TESANSFTLI GEASDGGTME NLSRRLKVTG
     DLFDIMSGQT DVDHPLCEEC TDTLLDQLDT QLNVTENECQ NYKRCLEILE QMNEDDSEQL
     QMELKELALE EERLIQELED VEKNRKIVAE NLEKVQAEAE RLDQEEAQYQ REYSEFKRQQ
     LELDDELKSV ENQMRYAQTQ LDKLKKTNVF NATFHIWHSG QFGTINNFRL GRLPSVPVEW
     NEINAAWGQT VLLLHALANK MGLKFQRYRL VPYGNHSYLE SLTDKSKELP LYCSGGLRFF
     WDNKFDHAMV AFLDCVQQFK EEVEKGETRF CLPYRMDVEK GKIEDTGGSG GSYSIKTQFN
     SEEQWTKALK FMLTNLKWGL AWVSSQFYNK
//
